LANTUSTITR: Insulin Glargine in Type 2 Diabetes Mellitus

Clinical trial NCT00349986 · TERMINATED

Trial details

NCT number: NCT00349986
Sponsor: Sanofi
Status: TERMINATED
Phase: Phase 4
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 2

Start date: 2006-09-01
Primary completion: 2007-06-01
Enrollment: 4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.